Cargando…
Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).
Cutaneous T-cell lymphoma is typically a clonal neoplasm of epidermotropic CD4+ T-lymphocytes that includes the entity mycosis fungoides (MF). After identification of patients with recurrent MF treated with total skin electron beam therapy (TSEBT) at the Yale University School of Medicine, this stud...
Autores principales: | Thayu, M., Tallini, G., Glusac, E. J., Kacinski, B. M., Wilson, L. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579043/ https://www.ncbi.nlm.nih.gov/pubmed/11138932 |
Ejemplares similares
-
Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides
por: Lebas, Eve, et al.
Publicado: (2017) -
Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
por: Denis, Daphné, et al.
Publicado: (2019) -
Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description
por: D’Agostino, Paolo, et al.
Publicado: (2020) -
Tumoral Melanosis Arising on a Mycosis Fungoides Plaque
por: Demirdağ, Hatice Gamze, et al.
Publicado: (2018) -
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
por: Crimp, Caitlin, et al.
Publicado: (2022)